Extraintestinal manifestations of inflammatory bowel diseases

被引:34
作者
Kethu, Sripathi R. [1 ]
机构
[1] Rhode Isl Hosp, Brown Sch Med, Dept Med, Div Gastroenterol, Providence, RI 02903 USA
关键词
inflammatory bowel disease; extraintestinal manifestations; Crohn disease; ulcerative colitis; autoimmunity;
D O I
10.1097/00004836-200607000-00003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel diseases are associated with extraintestinal manifestations involving almost every organ system in the body. They occur in approximately 20% to 40% of patients with inflammatory bowel diseases. Immune-related and genetic mechanisms play an important role in the pathogenesis of these complications. Peripheral arthritis, erythema nodosum, and episcleritis respond to the treatment of the underlying intestinal inflammation, whereas axial arthropathy, pyoderma gangrenosum, and uveitis do not. Immunomodulator therapy, particularly with biologic agents has been shown to be effective in treating some of the extraintestinal manifestations. Early recognition and treatment are crucial in preventing major morbidity.
引用
收藏
页码:467 / 475
页数:9
相关论文
共 92 条
[1]   Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis [J].
Baluyut, AR ;
Sherman, S ;
Lehman, GA ;
Hoen, H ;
Chalasani, N .
GASTROINTESTINAL ENDOSCOPY, 2001, 53 (03) :308-312
[2]   Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community [J].
Bambha, K ;
Kim, WR ;
Talwalkar, J ;
Torgerson, H ;
Benson, JT ;
Therneau, TM ;
Loftus, EV ;
Yawn, BP ;
Dickson, ER ;
Melton, LJ .
GASTROENTEROLOGY, 2003, 125 (05) :1364-1369
[3]   Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: Study of 511 subjects at a single center [J].
Bargiggia, S ;
Maconi, G ;
Elli, M ;
Molteni, P ;
Ardizzone, S ;
Parente, F ;
Todaro, I ;
Greco, S ;
Manzionna, G ;
Porro, GB .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (05) :417-420
[4]   Diagnosis and treatment of urinary tract complications in Crohn's disease: An experience over 15 years [J].
Ben-Ami, H ;
Ginesin, Y ;
Behar, DM ;
Fischer, D ;
Edoute, Y ;
Lavy, A .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 16 (04) :225-229
[5]  
Bernstein CN, 2001, AM J GASTROENTEROL, V96, P1116
[6]   The incidence of fracture among patients with inflammatory dowel disease - A population-based cohort study [J].
Bernstein, CN ;
Blanchard, JF ;
Leslie, W ;
Wajda, A ;
Yu, BN .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (10) :795-799
[7]  
Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430
[8]   Another look at fracture risk in IBD [J].
Bernstein, CN .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (06) :886-887
[9]   AGA technical review on osteoporosis in gastrointestinal diseases [J].
Bernstein, CN ;
Leslie, WD ;
Leboff, MS .
GASTROENTEROLOGY, 2003, 124 (03) :795-841
[10]   Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis [J].
Brandt, J ;
Khariouzov, A ;
Listing, J ;
Haibel, H ;
Sörensen, H ;
Grassnickel, L ;
Rudwaleit, M ;
Sieper, J ;
Braun, J .
ARTHRITIS AND RHEUMATISM, 2003, 48 (06) :1667-1675